New treatment strategy aims to stop rare liver cancer
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...
Cancer researchers have uncovered a signaling link – like a Snapchat between cells – that could be used to make tumors more vulnerable to therapy....
Clinical trials have long since proved that breast-conserving surgery combined with radiation therapy is an effective alternative to mastectomy. But uncertainty persists about the required doses...